Parker Waichman LLP Headlines by Topic
Concerta
ADHD Drug Study Finds Heart Death Risks for Kids, But FDA Says Recommendations Won't Change
Jun 16, 2009
| Parker Waichman LLP
While a new study has found that stimulant medications used to treat attention-deficit hyperactivity disorder (ADHD) may increase the risk of sudden...
American Children Take the Most Psychotropic Drugs
Sep 26, 2008
| Parker Waichman LLP
A new study reports that American children are about three times likelier to be prescribed psychotropic medications than children in Europe. ...
Screen for Kids for Heart Problems Before Prescribing ADHD Drugs, Heart Group Says
Apr 22, 2008
| Parker Waichman LLP
Children with Attention Deficit Hyperactivity Disorder (ADHD) should be screened for heart problems before they are prescribed stimulant drugs like...
ADHD drugmakers must tell of risks
Feb 23, 2007
| SOUTH FLORIDA SUN-SENTINEL
Federal officials told the makers of Ritalin, Adderall, Strattera and all other drugs for treatment of attention deficit hyperactivity disorder, or...
Government wants further ADHD drug warnings
Feb 22, 2007
| Baltimore Sun
The makers of Ritalin, Adderall, Strattera and other drugs treating attention-deficit hyperactivity disorder were advised by the government Wednesday...
ADHD drug makers to warn of side effects
Feb 21, 2007
| AP
Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart...
Drug makers to add warnings to ADHD pills
Feb 21, 2007
| AP
Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart...
ADHD Drugs to Get New Warnings
Feb 21, 2007
| NewsInferno.com
The U.S. Food and Drug Administration (FDA) announced today that it is ordering all manufacturers of attention deficit hyperactivity disorder (ADHD)...
FDA orders warning 'guides' for ADHD drugs
Feb 21, 2007
| USA Today
Pharmacists will soon begin handing out consumer-friendly "medication guides" about cardiovascular and psychiatric problems linked to...
FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Event
Feb 21, 2007
| www.fda.gov
The U.S. Food and Drug Administration (FDA) today directed the manufacturers of all drug products approved for the treatment of Attention Deficit...
